Expression screening using a Medaka cDNA library identifies evolutionarily conserved regulators of the p53/Mdm2...

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• The p53 tumor suppressor protein's stability is primarily controlled by its half-life, influencing cellular levels.
• Mdm2 is the main ubiquitin ligase targeting p53 for proteasomal degradation.
• Existing knowledge on p53/Mdm2 regulation is incomplete, with ongoing discovery of new interacting proteins and ubiquitin ligases.

Purpose of the Study:

• To identify evolutionarily conserved regulators of the p53/Mdm2 pathway using a cell culture-based overexpression screen.
• To enhance the understanding of how p53 and Mdm2 protein abundance and Mdm2 activity are regulated.

Main Methods:

• A large-scale overexpression screen was performed in H1299 cells using a Medaka cDNA library.
• Co-transfection with p53, Mdm2, and Ror2 (internal control) was followed by SDS-PAGE/Western Blot analysis.
• Identified Medaka genes were tested for their human orthologues' effects on p53/Mdm2 abundance.

Main Results:

• Over one hundred hits altering p53, Mdm2, or both protein levels were identified in the primary screen.
• Subscreening revealed several potential novel regulators of the p53/Mdm2 pathway.
• Human orthologues of identified Medaka genes confirmed conserved regulatory functions, validating the screening methodology.

Conclusions:

• Numerous unknown regulators of p53 and Mdm2 abundance are predicted to exist.
• A cross-species screening approach effectively identified evolutionarily conserved regulators.
• The Medaka unigene cDNA library is a valuable tool for discovering novel regulators in the p53/Mdm2 pathway.